TP53 and ovarian neoplasm: Furthermore, the p53R175H mutation ranks first among the p53 substitution mutations in cancer samples (S13D Fig), and p53R175H is not specific for any cancer type but is more frequently observed in large intestine, breast, haematopoietic, lymphoid, and ovary tumour samples (S13E Fig).